Austin, Texas, July 10, 2018 — Elligo Health Research, which offers the only platform that brings clinical research direct to clinical health care, has appointed former founder, executive chairman and CEO of Greenway Health, Wyche T. “Tee” Green III, as a director. Green has been a force behind the health care information technology (IT) movement since he co-founded Greenway Medical Technologies (now Greenway Health) in 1998.
Bridging the gap between clinical research and physician practices is the focus of Elligo’s approach. Green, who has dedicated nearly two decades to integrating and streamlining clinical, financial, administrative and patient-facing health care information systems, will provide Elligo with invaluable insight. While at Greenway, he invested in bringing clinical trials to thousands of providers and patients with a single mission: to improve health.
“We are honored and excited that Tee Green has accepted our invitation to join the board of directors,” said John Potthoff, Ph.D., CEO of Elligo. “This is a great leap for Elligo. We look forward to working with Tee as we refine our information systems and seek out new ways to make life-changing research accessible to all.”
“I’ve dedicated my career to improving population health by building a smarter, more sustainable health care system with advanced, integrated, information services,” said Green. “Increasing connectivity for the greater good is my passion, so when I realized Elligo was working to connect researchers with patients, I was intrigued.”
In addition to his work in health care IT and health care reform, Green has served on several additional boards ranging from the Auburn University Research Advisory Board to West Georgia Habitat for Humanity.
Elligo Health Research offers the only platform that brings clinical research to physician practices, accelerating the development of new pharmaceutical, biotechnology and medical device products and therapies. Our Goes Direct® approach uses state-of-the-art technology to compliantly leverage current electronic health record data and applies a proprietary, prescreening process to match protocol-eligible patients for participation in clinical studies. It is our mission to support health care providers by providing personnel, procedures, technology and infrastructure for clinical research, enabling patients to participate in research while remaining under the care of their own trusted physician. Learn more at elligodirect.com.